共 50 条
- [7] Longer Term Efficacy of Lanreotide Autogel/Depot (LAN) for Symptomatic Treatment of Carcinoid Syndrome (CS) in Neuroendocrine Tumor (NET) Patients from the ELECT Open Label Study [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S457 - S458
- [9] Efficacy of Lanreotide Autogel/Depot (LAN) vs Placebo (PBO) for Symptomatic Control of Carcinoid Syndrome (CS) in Neuroendocrine Tumor (NET) Patients from the ELECT Study [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S468 - S468